HCM
AMGN icon

Highline Capital Management’s Amgen AMGN Stock Holding History

Highline Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-426,200
Closed -$67.9M – 41
2014
Q4 		$67.9M Sell
426,200
-149,700
-26% -$23.3M 2.82% 17
2014
Q3 		$80.9M Sell
575,900
-468,400
-45% -$61.2M 3.15% 11
2014
Q2 		$124M Buy
1,044,300
+171,700
+20% +$19.9M 6.28% 2
2014
Q1 		$108M Buy
+872,600
New +$106M 7.39% 1

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Highline Capital Management's AMGN Position: Q1 2015 in Review

Highline Capital Management sold out of Amgen (AMGN) in Q1 2015, closing a stake of 388,537 shares — an estimated $61.9M sold.

Highline Capital Management first reported a position in AMGN in Q3 2013 and held it in 6 quarters. The position peaked at $80.8M in Q3 2013. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • Highline Capital Management reported no remaining Amgen position as of Q1 2015 after selling out during the quarter.
  • Highline Capital Management sold 388,537 Amgen shares in Q1 2015, an estimated $61.9M.
  • Highline Capital Management first reported a position in Amgen in Q3 2013 and held it in 6 quarters.
  • Highline Capital Management's Amgen position peaked at $80.8M in Q3 2013.
  • 1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Highline Capital Management's 13F filing for Q1 2015, filed 15 May 2015.